Tapewire

Nasdaq · USD

VNDA

Vanda Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
5861
SEC CIK
0001347178
Parsed reports
233

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202605
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2021 Filed Mar 16, 2021 20:20 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 18,000 $17.72 $319,010.40
Disclosure

SEC source: 0001209191-21-020782 · doc4.xml · nonDerivative · entry 2

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,935

F1 · kind: A portion of the shares were sold to satisfy the exercise price and tax obligations relating to the acquisition of the shares in connection with the stock option exercise.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.69 to $17.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 15, 2021 Filed Mar 16, 2021 20:20 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionCommon Stock 15,000 $11.32 $169,800.00
Disclosure

SEC source: 0001209191-21-020782 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 22:15 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 175,000 $18.00 $3,150,052.50
Disclosure

SEC source: 0001209191-21-019118 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,221,062

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 22:47 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 5,400 $17.85 $96,390.00
Disclosure

SEC source: 0001209191-21-018651 · doc4.xml · nonDerivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,926

Read SEC document
March 05, 2021 Filed Mar 8, 2021 22:47 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 200 $17.88 $3,576.00
Disclosure

SEC source: 0001209191-21-018651 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,326

Read SEC document
March 02, 2021 Filed Mar 3, 2021 18:40 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 6,044 $18.23 $110,190.58
Disclosure

SEC source: 0001209191-21-017274 · doc4.xml · nonDerivative · entry 2

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,426

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 23:43 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 7,674 $18.54 $142,307.42
Disclosure

SEC source: 0001209191-21-017280 · doc4.xml · nonDerivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,526

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.33 to $18.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 18:39 UTC
Birznieks GuntherSVP, Business Development
SaleCommon Stock 16,620 $18.19 $302,272.93
Disclosure

SEC source: 0001209191-21-017272 · doc4.xml · nonDerivative · entry 2

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,708

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 23:42 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 3,888 $18.45 $71,728.93
Disclosure

SEC source: 0001209191-21-017278 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,202

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.37 to $18.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 23:41 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 15,206 $18.34 $278,902.37
Disclosure

SEC source: 0001209191-21-017276 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,396,062

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.26 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 23:40 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 3,865 $18.04 $69,717.26
Disclosure

SEC source: 0001209191-21-017273 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,935

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 18:40 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 3,327 $18.57 $61,780.06
Disclosure

SEC source: 0001209191-21-017274 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,470

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.55 to $18.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:43 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 11,856 $18.60 $220,542.94
Disclosure

SEC source: 0001209191-21-017280 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,200

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 18:39 UTC
Birznieks GuntherSVP, Business Development
SaleCommon Stock 3,845 $18.66 $71,743.86
Disclosure

SEC source: 0001209191-21-017272 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,328

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.53 to $18.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:41 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 7,479 $18.45 $138,002.51
Disclosure

SEC source: 0001209191-21-017276 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,411,268

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.32 to $18.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:17 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantEmployee Stock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014876 · doc4.xml · derivative · entry 3

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2031-02-23

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:17 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantCommon Stock 32,700 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014876 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,797

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:19 UTC
Williams TimothySVP & General Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014886 · doc4.xml · derivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2031-02-23

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:19 UTC
Williams TimothySVP & General Counsel
GrantCommon Stock 32,700 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014886 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,056

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:15 UTC
Birznieks GuntherSVP, Business Development
GrantEmployee Stock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014869 · doc4.xml · derivative · entry 2

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2031-02-23

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:15 UTC
Birznieks GuntherSVP, Business Development
GrantCommon Stock 32,700 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014869 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,173

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:19 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 61,200 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014882 · doc4.xml · derivative · entry 2

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,200

Underlying: Common Stock · 61,200 shares

Expires 2031-02-23

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:19 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantCommon Stock 25,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014882 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,090

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:17 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 22,499 $0.00 Strike: $12.27 $0.00
Disclosure

SEC source: 0001209191-21-014873 · doc4.xml · derivative · entry 5

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,501

Underlying: Common Stock · 22,499 shares

Expires 2029-07-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested and became exercisable with respect to 25% of the shares subject to the option on July 25, 2020, and the remaining 75% of the shares vests in 36 equal monthly installments beginning August 25, 2020, provided the Reporting Person remains continuously employed by the issuer through each monthly vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:17 UTC
Jones Aranthan IIChief Corp. Affairs Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 61,200 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014873 · doc4.xml · derivative · entry 4

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,200

Underlying: Common Stock · 61,200 shares

Expires 2031-02-23

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:17 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 22,986 $20.01 $460,032.61
Disclosure

SEC source: 0001209191-21-014873 · doc4.xml · nonDerivative · entry 3

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,800

F2 · kind: A portion of the shares were sold to satisfy the exercise price and tax obligations relating to the acquisition of the shares in connection with the stock option exercise.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:17 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionCommon Stock 22,499 $12.27 $276,062.73
Disclosure

SEC source: 0001209191-21-014873 · doc4.xml · nonDerivative · entry 2

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:17 UTC
Jones Aranthan IIChief Corp. Affairs Officer
GrantCommon Stock 25,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014873 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,287

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:18 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 275,000 $0.00 Strike: $20.28 $0.00
Disclosure

SEC source: 0001209191-21-014878 · doc4.xml · derivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2031-02-23

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:18 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
GrantCommon Stock 115,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-014878 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,418,747

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 01:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $7.11 $0.00
Disclosure

SEC source: 0001209191-21-012204 · doc4.xml · derivative · entry 3

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in 12 equal monthly installments beginning on July 16, 2011.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 01:43 UTC SaleCommon Stock 5,754 $18.54 $106,663.05
Disclosure

SEC source: 0001209191-21-012204 · doc4.xml · nonDerivative · entry 2

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,887

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 15, 2021 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 01:43 UTC Exercise / conversionCommon Stock 15,000 $7.11 $106,650.00
Disclosure

SEC source: 0001209191-21-012204 · doc4.xml · nonDerivative · entry 1

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 20:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $7.11 $0.00
Disclosure

SEC source: 0001209191-21-012205 · doc4.xml · derivative · entry 3

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in 12 equal monthly installments beginning on July 16, 2011.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 20:43 UTC SaleCommon Stock 5,818 $18.54 $107,855.83
Disclosure

SEC source: 0001209191-21-012205 · doc4.xml · nonDerivative · entry 2

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,505

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 15, 2021 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.43 to $18.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 20:43 UTC Exercise / conversionCommon Stock 15,000 $7.11 $106,650.00
Disclosure

SEC source: 0001209191-21-012205 · doc4.xml · nonDerivative · entry 1

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,323

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 46,663 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · derivative · entry 9

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,663 shares

Expires 2020-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in 48 equal monthly installments from the date of grant.

Read SEC document
December 15, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 39,150 $13.00 $508,844.30
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 6

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,303,747

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.85 to $13.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
December 15, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionCommon Stock 46,663 $8.75 $408,301.25
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 5

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,342,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 14, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 61,520 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · derivative · entry 8

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,663

Underlying: Common Stock · 61,520 shares

Expires 2020-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in 48 equal monthly installments from the date of grant.

Read SEC document
December 14, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 51,049 $13.19 $673,305.68
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 4

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,296,234

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.15 to $13.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 14, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionCommon Stock 61,520 $8.75 $538,300.00
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 3

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,347,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 11, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 41,817 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · derivative · entry 7

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,183

Underlying: Common Stock · 41,817 shares

Expires 2020-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in 48 equal monthly installments from the date of grant.

Read SEC document
December 11, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 35,053 $12.88 $451,359.95
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,285,763

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
December 11, 2020 Filed Dec 15, 2020 21:24 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionCommon Stock 41,817 $8.75 $365,898.75
Disclosure

SEC source: 0001209191-20-063474 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,320,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2020 Filed Aug 21, 2020 22:08 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 3,710 $11.08 $41,109.03
Disclosure

SEC source: 0001209191-20-047991 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,290

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 20:42 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 3,684 $11.81 $43,526.09
Disclosure

SEC source: 0001209191-20-046965 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,356

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.79 to $11.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 12, 2020 Filed Aug 14, 2020 20:39 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 7,200 $11.81 $85,018.32
Disclosure

SEC source: 0001209191-20-046804 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,487

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $11.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 20:19 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantStock Option (Right to Buy) · Derivative 90,000 $0.00 Strike: $10.83 $0.00
Disclosure

SEC source: 0001209191-20-043999 · doc4.xml · derivative · entry 3

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2030-07-26

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on July 27, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 20:19 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantCommon Stock 17,344 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-043999 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,097

F1 · price: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on July 27, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.